Purex Laboratories (India) Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 18-07-2024
- Paid Up Capital ₹ 1.49 M
as on 18-07-2024
- Company Age 51 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.15 Cr
as on 18-07-2024
- Satisfied Charges ₹ 5.20 M
as on 18-07-2024
- Revenue -5.18%
(FY 2022)
- Profit -32.57%
(FY 2022)
- Ebitda -4.77%
(FY 2022)
- Net Worth 7.14%
(FY 2022)
- Total Assets -4.92%
(FY 2022)
About Purex Laboratories (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.49 M.
The company currently has active open charges totaling ₹2.15 Cr. The company has closed loans amounting to ₹5.20 M, as per Ministry of Corporate Affairs (MCA) records.
Vivek Kothapalli, Bhagyalakshmi Kothapalli, and Ravibabu Kothapalli serve as directors at the Company.
- CIN/LLPIN
U24100KA1972PTC002281
- Company No.
002281
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 1972
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Purex Laboratories (India) Private Limited offer?
Purex Laboratories (India) Private Limited offers a wide range of products and services, including Cattle Feed, Linseed Cake, Herbs,Sticks and Roots, Ayurvedic Indian Herbs, Masala Powder, Ginger Powder, Seed Spices, Methi Dana, Jivanti Herb, Medicinal Roots.
Who are the key members and board of directors at Purex Laboratories (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravibabu Kothapalli  | Managing Director | 25-Jul-1994 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Kothapalli | Director | 17-Nov-2022 | Current |
| Bhagyalakshmi Kothapalli | Whole-Time Director | 02-Apr-1992 | Current |
Financial Performance of Purex Laboratories (India).
Purex Laboratories (India) Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 5.18% decrease. The company also saw a substantial fall in profitability, with a 32.57% decrease in profit. The company's net worth moved up by a moderate rise of 7.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Purex Laboratories (India)?
In 2021, Purex Laboratories (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Oct 2020 | ₹1.57 M | Open |
Others Creation Date: 30 Aug 2017 | ₹2.50 M | Open |
Syndicate Bank Creation Date: 12 Jan 2004 | ₹1.00 M | Open |
How Many Employees Work at Purex Laboratories (India)?
Unlock and access historical data on people associated with Purex Laboratories (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Purex Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Purex Laboratories (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
